Financial Ratios

DENIS CHEM LAB LTD.

NSE : NABSE : 537536ISIN CODE : INE051G01012Industry : Pharmaceuticals & DrugsHouse : Private
BSE82.545.47 (+7.1 %)
PREV CLOSE ( ) 77.07
OPEN PRICE ( ) 79.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 11859
TODAY'S LOW / HIGH ( )79.30 84.81
52 WK LOW / HIGH ( ) 72.35136
NSE
This Company is not listed in NSE
Select year
ParticularsMar2025Mar2024Mar2023Mar2022Mar2021
Operational & Financial Ratios
   Earnings Per Share (Rs)5.828.045.664.511.63
   CEPS(Rs)10.7613.0411.308.665.93
   DPS(Rs)1.502.502.001.500.75
   Book NAV/Share(Rs)61.3357.9152.0847.8944.32
   Tax Rate(%)27.3226.2828.0029.5026.65
Margin Ratios
   Core EBITDA Margin(%)9.3012.6511.6810.519.38
   EBIT Margin(%)6.719.347.197.064.25
   Pre Tax Margin(%)6.419.026.796.512.82
   PAT Margin (%)4.666.654.894.592.07
   Cash Profit Margin (%)8.6210.799.758.807.52
Performance Ratios
   ROA(%)7.2910.698.036.642.39
   ROE(%)9.7614.6211.339.793.76
   ROCE(%)13.8920.1516.0713.796.50
   Asset Turnover(x)1.561.611.641.451.15
   Sales/Fixed Asset(x)1.501.571.591.391.16
   Working Capital/Sales(x)3.903.984.574.884.66
Efficiency Ratios
   Fixed Capital/Sales(x)0.670.640.630.720.87
   Receivable days65.5868.4071.5786.49113.29
   Inventory Days21.0621.0021.5725.3929.45
   Payable days81.2783.3982.0689.23111.66
Valuation Parameters
   PER(x)15.9218.7611.2615.1022.89
   PCE(x)8.6111.565.657.876.30
   Price/Book(x)1.512.601.221.420.84
   Yield(%)1.621.663.142.202.01
   EV/Net Sales(x)0.601.100.460.650.51
   EV/Core EBITDA(x)5.588.193.795.785.27
   EV/EBIT(x)8.8811.826.369.2312.05
   EV/CE(x)1.202.280.990.920.61
   M Cap / Sales0.741.250.550.690.47
Growth Ratio
   Net Sales Growth(%)3.264.3417.7924.92-19.71
   Core EBITDA Growth(%)-18.2916.7725.8245.27-30.65
   EBIT Growth(%)-25.8635.6419.89107.72-46.15
   PAT Growth(%)-27.6141.9325.50176.59-46.26
   EPS Growth(%)-27.6141.9425.50176.59-46.27
Financial Stability Ratios
   Total Debt/Equity(x)0.010.010.030.050.14
   Current Ratio(x)2.702.552.462.111.93
   Quick Ratio(x)2.322.182.081.721.57
   Interest Cover(x)22.7728.8618.0212.742.99
   Total Debt/Mcap(x)0.010.000.020.030.17

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.